Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

IONIS PHARMACEUTICAL, INC.

Filed by FORBES-TATE.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 19, 2025
Income
$30,000.00
Expenses
Not reported
Registrant
FORBES-TATE
Filing UUID
bc4ecba6-d790-4d11-9eb3-af456e531dbe
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to the reintroduction of the Creating Hope Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.

Literal federal measure citations: H.R. 1672

MMM · Medicare/Medicaid

Issues related to the reintroduction of the Creating Hope Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.

Literal federal measure citations: H.R. 1672

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.